Arcus Biosciences RCUS Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$353M-24.7% | -$283M+7.8% | -$307M-15.0% | -$267M-604% | ||
| $10M0.0% | $10M+25.0% | $8M+33.3% | $6M+50.0% | ||
| $60M-21.1% | $76M+4.1% | $73M+12.3% | $65M+18.2% | ||
| -$482M— | —— | -$306M— | —— | ||
| —— | $6M-75.0% | $24M+300% | $6M-76.9% | ||
| —— | —— | $194M— | —— | ||
| $488M+74.9% | $279M+745% | $33M0.0% | $33M-86.1% | ||
| —— | —— | -$79M— | —— | ||
| -$484M— | —— | -$330M— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where does Arcus Biosciences's cash flow data come from?
- Every line is extracted from Arcus Biosciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.